Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2023-04-26 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
第二届监事会第十八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Huizhou Jin Hao Medical Technology Co., Ltd. It details the convening and attendance of the 18th meeting of the 2nd Supervisory Board, including the approval of the company's 2023 Q1 report. The document references the actual quarterly report being published elsewhere (on the Beijing Stock Exchange disclosure platform) and does not contain the financial data or substantive analysis itself. The document is short (772 characters) and serves as an announcement of the meeting resolution and approval of the quarterly report, not the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice rather than an Interim/Quarterly Report (IR) or Report Publication Announcement (RPA).
2023-04-26 Chinese
第二届董事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 25th meeting of the second board of directors of Huizhou Jin Hao Medical Technology Co., Ltd. It details the meeting's attendance, agenda items, and voting results. The document references the approval of the company's 2023 first quarter report and other corporate matters but does not contain the report itself or detailed financial data. It is a board meeting resolution announcement, not a full management report or financial report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2023-04-26 Chinese
中信建投证券股份有限公司关于惠州市锦好医疗科技股份有限公司变更部分募投项目实际用途的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed special verification opinion from a sponsoring securities company regarding the change in the actual use of part of the raised funds by a listed company. It includes detailed information about the fundraising, usage, project adjustments, and the approval process by the board and supervisory committee. It references regulatory rules related to securities issuance and listing, and it is a formal verification report by the sponsor on the use of proceeds. This type of document is not a full annual or interim report, nor is it a simple announcement or certification. It is a specialized audit or verification report related to fundraising and project use compliance. Therefore, it fits best under the category 'Audit Report / Information (AR)', which covers standalone audit reports and applied accounting principles related to regulatory compliance and internal checks, excluding full annual reports.
2023-04-16 Chinese
2022年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for 惠州市锦好医疗科技股份有限公司, with a specific audit report number and dated April 13, 2023. It contains detailed auditor opinions, audit basis, key audit matters, management responsibilities, and extensive financial statements including balance sheets and profit statements for the fiscal year ending December 31, 2022. The content is consistent with a standalone audit report rather than a full annual report or other filing types. The length is substantial (15,000 characters) and contains actual financial data and auditor commentary, not just an announcement or certification. Therefore, the document fits the category of Audit Report / Information (AR).
2023-04-16 Chinese
第二届董事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Huizhou Jin Hao Medical Technology Co., Ltd. It includes voting results on various proposals related to the 2022 annual report, audit report, financial statements, and other corporate governance matters. The document references that the actual 2022 annual report, audit report, and other detailed reports are disclosed separately on the Beijing Stock Exchange platform, indicating this document itself is not the full annual report or audit report but a board meeting resolution announcement. The content is focused on board decisions and approvals rather than the full financial or audit reports themselves. Therefore, this document fits best into the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it contains substantive board meeting details and voting results, not just a brief announcement of report publication, so it is not an RPA. Hence, the classification is MANG with high confidence.
2023-04-16 Chinese
信息披露事务管理制度
Governance Information Classification · 95% confidence The document is titled "信息披露事务管理制度" which translates to "Information Disclosure Management System". It is a detailed internal policy document outlining the company's procedures and responsibilities for information disclosure, including definitions, reporting requirements, board and shareholder meeting disclosures, transaction disclosures, related party transactions, risk disclosures, confidentiality, and responsibility mechanisms. It references regulatory frameworks and stock exchange rules but does not contain any financial statements, audit opinions, earnings data, or specific event announcements. It is not a report of financial results, nor an announcement of a report, nor a transcript or presentation. It is a governance-related document detailing internal rules and practices for information disclosure management. Therefore, it fits best under Governance Information (CGR). The document length (over 14,000 characters) and content confirm it is a substantive governance policy document, not a brief announcement or regulatory filing.
2023-04-16 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.